2022 IPO

Greenlight Biosciences Stock

Unconstrained Metabolism(R) technology platform to produce sustainable chemicals and fuels

Sign up today and learn more about Greenlight Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Greenlight Biosciences Stock

GreenLight Biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its Unconstrained Metabolism ® technology platform. This revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.

Funding History

August 2013$7.0M
December 2013$1.0M
June 2015$20.0M
July 2015$0
September 2017$18.0M
January 2019$50.0M


Co-Founder, CEO

Andrey Zarur

Co-Founder, Chief Scientific Advisor

James Swartz

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: